NFKB1 and breast carcinoma: Inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation by Ex-4 has been shown to attenuate breast cancer cell proliferation [77], while inhibitory effects of the same molecule on activation of the ERK-MAPK pathway resulted in limited growth of prostate cancer cell lines [78].